• ArriVent BioPharma Reports Third Quarter 2025 Financial Results The Globe and Mail Mon, 10 Nov 2025 14:12:40 GMT
• why arrivent biopharma inc. stock is popular among millennials - july 2025 preearnings & expert approved momentum trade ideas Fundação Cultural do Pará Thu, 06 Nov 2025 02:47:19 GMT
• moody aldrich partners llc takes $1.56 million position in arrivent biopharma, inc. $avbp MarketBeat Sat, 01 Nov 2025 09:59:46 GMT
• why retail investors pile into arrivent biopharma inc. stock - 2025 fundamental recap & smart investment allocation insights Fundação Cultural do Pará Tue, 28 Oct 2025 22:21:10 GMT
• why arrivent biopharma inc. stock remains a top recommendation - july 2025 levels & weekly breakout opportunity watchlist fcp.pa.gov.br Tue, 28 Oct 2025 05:46:21 GMT
• why arrivent biopharma inc. stock could benefit from ai revolution - july 2025 movers & technical pattern based buy signals newser.com Sun, 26 Oct 2025 17:58:36 GMT
• how arrivent biopharma inc. stock reacts to fed rate cuts - july 2025 wrapup & daily volume surge signals newser.com Sun, 26 Oct 2025 05:40:19 GMT
• arrivent biopharma, inc. (avbp) stock analysis: unveiling a huge 118% potential upside in biotech DirectorsTalk Interviews Fri, 24 Oct 2025 09:45:08 GMT
• how arrivent biopharma inc. stock reacts to fed rate cuts - 2025 market trends & technical buy zone confirmation newser.com Tue, 21 Oct 2025 21:34:24 GMT
• why arrivent biopharma inc. stock is favored by pension funds - options play & weekly breakout watchlists newser.com Tue, 21 Oct 2025 19:05:56 GMT
• is arrivent biopharma inc. stock a safe investment in uncertain markets - layoff news & fast moving stock trade plans Trung tâm Dự báo KTTV quốc gia Sat, 18 Oct 2025 11:23:20 GMT
• is arrivent biopharma inc. stock attractive after correction - quarterly market review & weekly top gainers alerts Trung tâm Dự báo KTTV quốc gia Sat, 18 Oct 2025 10:32:03 GMT
• arrivent biopharma, inc. (avbp) stock analysis: unveiling a 101.56% potential upside in the biotech space DirectorsTalk Interviews Fri, 17 Oct 2025 09:21:14 GMT
• arrivent biopharma, inc. (avbp) stock analysis: a promising 87% upside in the biotech sector DirectorsTalk Interviews Fri, 10 Oct 2025 07:00:00 GMT
• arrivent biopharma, inc. (avbp): investor outlook on a high-upside biotech stock with 110% potential gain DirectorsTalk Interviews Fri, 03 Oct 2025 07:00:00 GMT
• certain common stock of arrivent biopharma, inc. are subject to a lock-up agreement ending on 1-oct-2025. MarketScreener Wed, 01 Oct 2025 01:06:56 GMT
• Certain Common Stock of ArriVent BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. MarketScreener Tue, 30 Sep 2025 07:00:00 GMT
• is arrivent biopharma inc. stock attractive after correction - analyst upgrade & breakout confirmation alerts newser.com Fri, 26 Sep 2025 19:29:44 GMT
• can daiwa securities group inc. (common stock) (dse0) stock deliver strong annual returns - weekly trend recap & free weekly watch... newser.com Fri, 26 Sep 2025 17:51:41 GMT
• what rsi levels show for innate pharma s.a. (common stock) (idda) stock - quarterly performance summary & precise swing trade aler... newser.com Fri, 26 Sep 2025 17:02:11 GMT
• how strong dollar benefits holcim ag (common stock) (hlb) stock - market trend report & verified stock trade ideas newser.com Fri, 26 Sep 2025 05:54:51 GMT
• why miata metals corp. (8nq) stock is a must watch ticker - 2025 price action summary & weekly high return forecasts newser.com Fri, 26 Sep 2025 04:22:19 GMT
• goldman sachs group inc. trims position in arrivent biopharma, inc. $avbp MarketBeat Tue, 23 Sep 2025 08:47:35 GMT
• oncology biotech arrivent biopharma taps 25-year industry veteran to lead lung cancer drug launch Stock Titan Mon, 22 Sep 2025 07:00:00 GMT
• how moving averages guide arrivent biopharma inc. trading - stop loss & free weekly watchlist of top performers newser.com Mon, 22 Sep 2025 05:49:47 GMT
• is arrivent biopharma inc. forming a bottoming base - weekly trend report & consistent income trade ideas newser.com Sun, 21 Sep 2025 11:43:10 GMT
• arrivent biopharma, inc. $avbp shares sold by goldman sachs group inc. MarketBeat Sun, 21 Sep 2025 07:21:56 GMT
• goldman sachs group inc. has $1.42 million stake in arrivent biopharma, inc. $avbp MarketBeat Sun, 21 Sep 2025 07:21:56 GMT
• is arrivent biopharma inc. stock ready for a breakout - portfolio profit report & free community consensus stock picks newser.com Sun, 21 Sep 2025 02:09:10 GMT
• custom watchlist performance reports with arrivent biopharma inc. - market risk summary & fast gain swing alerts newser.com Sat, 20 Sep 2025 00:21:26 GMT
• real time social sentiment graph for riverview bancorp inc. - market sentiment review & weekly high return stock forecasts newser.com Fri, 19 Sep 2025 06:47:11 GMT
• arrivent biopharma (nasdaq:avbp) stock price down 4.7% - here's what happened MarketBeat Mon, 15 Sep 2025 07:00:00 GMT
• arrivent biopharma, inc. (nasdaq:avbp) receives $39.14 average target price from analysts MarketBeat Mon, 15 Sep 2025 07:00:00 GMT
• infinitum asset management llc has $38.21 million stock position in arrivent biopharma, inc. $avbp MarketBeat Fri, 12 Sep 2025 07:00:00 GMT
• 16-month survival breakthrough: arrivent's new lung cancer drug shows promising cns response in global trial Stock Titan Tue, 09 Sep 2025 07:00:00 GMT
• how high can arrivent biopharma inc. stock go - 2025 top decliners & reliable price breakout alerts Newser Tue, 02 Sep 2025 05:32:26 GMT
• can arrivent biopharma inc. hit a new high this month - july 2025 short interest & low risk growth stock ideas Newser Mon, 01 Sep 2025 20:26:08 GMT
• automated trading signals detected on arrivent biopharma inc. - 2025 technical patterns & ai driven price predictions Newser Sun, 31 Aug 2025 09:52:33 GMT
• is this a good reentry point in arrivent biopharma inc. - weekly profit analysis & free expert approved momentum trade ideas Newser Sat, 30 Aug 2025 19:41:07 GMT
• will arrivent biopharma inc. outperform the market - 2025 earnings impact & low volatility stock recommendations Newser Sat, 30 Aug 2025 05:26:37 GMT
• arrivent biopharma inc. stock prediction for this week - quarterly earnings report & weekly watchlist for hot stocks Newser Fri, 29 Aug 2025 23:02:57 GMT
• will arrivent biopharma inc. stock go up soon - quarterly portfolio summary & free low drawdown momentum trade ideas Newser Thu, 28 Aug 2025 06:11:18 GMT
• how to interpret rsi for arrivent biopharma inc. stock - quarterly earnings summary & verified swing trading watchlist Newser Wed, 27 Aug 2025 20:45:36 GMT
• how hedge fund analytics apply to arrivent biopharma inc. stock - portfolio value report & reliable price breakout alerts Newser Wed, 27 Aug 2025 10:36:48 GMT
• will arrivent biopharma inc. stock go up soon - trade performance summary & safe swing trade setups Newser Wed, 27 Aug 2025 09:53:55 GMT
• will arrivent biopharma inc. stock go up soon - buy signal & reliable price breakout signals Newser Tue, 26 Aug 2025 20:18:12 GMT
• what indicators show strength in arrivent biopharma inc. - entry point & fast moving market watchlists Newser Tue, 26 Aug 2025 19:01:53 GMT
• arrivent biopharma inc. stock momentum explained - weekly trend recap & consistent profit alerts Newser Tue, 26 Aug 2025 18:14:49 GMT
• will arrivent biopharma inc. stock go up soon - market sentiment summary & reliable entry point alerts Newser Sat, 23 Aug 2025 05:14:15 GMT
• is arrivent biopharma inc. stock bottoming out - price action & daily oversold stock bounce ideas Newser Wed, 20 Aug 2025 07:00:23 GMT
• arrivent biopharma inc. stock momentum explained - treasury yields & daily chart pattern signal reports Newser Wed, 20 Aug 2025 05:59:44 GMT
• arrivent biopharma reports second quarter 2025 financial results The Manila Times Mon, 11 Aug 2025 12:09:26 GMT
• ArriVent's Lung Cancer Drug Shows Promise in Phase 1b Trial, Reports $335M Cash Position Stock Titan Mon, 11 Aug 2025 07:00:00 GMT
• arrivent biopharma reports positive interim phase 1b results for firmonertinib in egfr pacc mutant nsclc and highlights key financ... Quiver Quantitative Mon, 11 Aug 2025 07:00:00 GMT
• tools to monitor arrivent biopharma inc. recovery probability - ai powered stock trend prediction model Newser Mon, 04 Aug 2025 03:48:21 GMT
• arrivent biopharma, inc. (nasdaq:avbp) receives consensus rating of “buy” from analysts Defense World Wed, 23 Jul 2025 20:17:47 GMT
• arrivent biopharma, inc. (avbp) receives a buy from b.riley financial The Globe and Mail Wed, 23 Jul 2025 07:00:00 GMT
• arrivent biopharma inc. stock analysis and forecast - overwhelming profit margins jammulinksnews.com Wed, 23 Jul 2025 04:09:50 GMT
• arrivent biopharma stock maintains buy rating at h.c. wainwright Investing.com Tue, 22 Jul 2025 07:00:00 GMT
• arrivent biopharma inc. stock analysis and forecast - overwhelming profit margins Jammu Links News Tue, 22 Jul 2025 07:00:00 GMT
• arrivent biopharma stock steady as oppenheimer reiterates outperform rating Investing.com Mon, 21 Jul 2025 07:00:00 GMT
• arrivent expects topline data from lung cancer drug trial in early 2026 Investing.com Mon, 21 Jul 2025 07:00:00 GMT
• is arrivent biopharma inc. stock a growth or value play - free capital allocation plans Newser Fri, 18 Jul 2025 07:13:06 GMT
• arrivent biopharma (nasdaq:avbp) pt set at $33.00 by the goldman sachs group Defense World Sat, 12 Jul 2025 07:00:00 GMT
• Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering Mintz Tue, 08 Jul 2025 07:00:00 GMT
• arrivent biopharma stock maintains buy rating at clear street despite competitor approval Investing.com Thu, 03 Jul 2025 07:00:00 GMT
• arrivent biopharma announces $75 million public offering The Globe and Mail Thu, 03 Jul 2025 07:00:00 GMT
• latham & watkins advises on arrivent’s us$75 million common stock offering and pre-funded warrants Latham & Watkins LLP Thu, 03 Jul 2025 00:29:02 GMT
• Watkins Advises on ArriVent’s US$75 Million Common Stock Offering and Pre-Funded Warrants Latham & Watkins LLP Wed, 02 Jul 2025 07:00:00 GMT
• Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Benzinga Wed, 02 Jul 2025 07:00:00 GMT
• ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants The Manila Times Wed, 02 Jul 2025 07:00:00 GMT
• latham & watkins advises on arrivent’s us$75 million common stock offering and pre-funded warrants Latham & Watkins LLP Wed, 02 Jul 2025 07:00:00 GMT
• $75m stock offering: how arrivent biopharma plans to accelerate cancer drug development Stock Titan Wed, 02 Jul 2025 03:17:58 GMT
• arrivent announces pricing of $75 million public offering of common stock and pre-funded warrants TradingView Wed, 02 Jul 2025 03:15:00 GMT
• Biotech ArriVent BioPharma Seeks $75M in Fresh Capital to Advance Cancer Drug Pipeline Stock Titan Tue, 01 Jul 2025 07:00:00 GMT
• $75M Stock Offering: How ArriVent BioPharma Plans to Accelerate Cancer Drug Development Stock Titan Tue, 01 Jul 2025 07:00:00 GMT
• arrivent biopharma announces $75 million public offering Investing.com Tue, 01 Jul 2025 07:00:00 GMT
• arrivent announces pricing of $75 million public offering of common stock and pre-funded warrants TradingView Tue, 01 Jul 2025 07:00:00 GMT
• arrivent announces proposed $75 million public offering of common stock and pre-funded warrants TradingView Tue, 01 Jul 2025 07:00:00 GMT
• arrivent biopharma (nasdaq:avbp) given buy rating at guggenheim Defense World Wed, 25 Jun 2025 11:27:41 GMT
• arrivent biopharma (nasdaq:avbp) price target raised to $44.00 at oppenheimer Defense World Wed, 25 Jun 2025 07:07:49 GMT
• arrivent biopharma (nasdaq:avbp) shares gap up after analyst upgrade Defense World Wed, 25 Jun 2025 07:00:00 GMT
• sg americas securities llc boosts stock position in arrivent biopharma, inc. (nasdaq:avbp) Defense World Wed, 25 Jun 2025 07:00:00 GMT
• oppenheimer adjusts arrivent biopharma price target to $44 from $39, maintains outperform rating MarketScreener Tue, 24 Jun 2025 12:28:18 GMT
• arrivent biopharma inc (avbp) stock: navigating a year of stock volatility investchronicle.com Tue, 24 Jun 2025 11:41:41 GMT
• arrivent biopharma says interim results from lung cancer drug trial showed 16 months median progression-free survival MarketScreener Mon, 23 Jun 2025 12:16:16 GMT
• breakthrough: new lung cancer drug achieves 16-month progression-free survival with 41% brain response rate Stock Titan Mon, 23 Jun 2025 07:00:00 GMT
• arrivent to unveil next steps for breakthrough egfr pacc lung cancer drug firmonertinib Stock Titan Fri, 20 Jun 2025 07:00:00 GMT
• gamma investing llc acquires 2,611 shares of arrivent biopharma, inc. (nasdaq:avbp) Defense World Fri, 20 Jun 2025 07:00:00 GMT
• ubs am a distinct business unit of ubs asset management americas llc purchases new holdings in arrivent biopharma, inc. (nasdaq:av... Defense World Fri, 13 Jun 2025 07:00:00 GMT
• arrivent biopharma, inc. (avbp) stock analysis: uncovering an 88% upside with strong buy ratings DirectorsTalk Interviews Fri, 30 May 2025 07:00:00 GMT
• arrivent biopharma (nasdaq:avbp) shares down 4.5% – here’s what happened Defense World Sun, 25 May 2025 08:48:44 GMT
• price t rowe associates inc. md has $293,000 stock holdings in arrivent biopharma, inc. (nasdaq:avbp) Defense World Fri, 16 May 2025 07:00:00 GMT
• arrivent biopharma, inc. reports earnings results for the first quarter ended march 31, 2025 marketscreener.com Mon, 12 May 2025 15:40:18 GMT
• ArriVent BioPharma Reports First Quarter 2025 Financial Results The Manila Times Mon, 12 May 2025 07:00:00 GMT
• allied gold announces share consolidation in connection with intention to list on the new york stock exchange The Globe and Mail Thu, 08 May 2025 07:00:00 GMT
• arrivent biopharma, inc. (nasdaq:avbp) shares acquired by wells fargo & company mn Defense World Mon, 05 May 2025 07:00:00 GMT
• invesco ltd. takes position in arrivent biopharma, inc. (nasdaq:avbp) Defense World Sun, 04 May 2025 08:55:47 GMT
• barclays plc grows holdings in arrivent biopharma, inc. (nasdaq:avbp) Defense World Sun, 04 May 2025 07:00:00 GMT
• arrivent biopharma, inc. (nasdaq:avbp) shares acquired by jpmorgan chase & co. Defense World Fri, 02 May 2025 13:22:17 GMT
• legal & general group plc purchases 10,783 shares of arrivent biopharma, inc. (nasdaq:avbp) Defense World Thu, 01 May 2025 07:00:00 GMT
• arrivent biopharma (avbp) strengthens leadership with new board appointment | avbp stock news GuruFocus Mon, 28 Apr 2025 12:30:16 GMT
• ex-gilead chief medical officer strengthens arrivent leadership as breakthrough cancer drug advances Stock Titan Mon, 28 Apr 2025 07:00:00 GMT
• vanguard group inc. has $37.76 million stock holdings in arrivent biopharma, inc. (nasdaq:avbp) Defense World Mon, 14 Apr 2025 10:01:51 GMT
• 41,921 shares in arrivent biopharma, inc. (nasdaq:avbp) bought by wellington management group llp Defense World Mon, 14 Apr 2025 07:00:00 GMT
• klp kapitalforvaltning as purchases new shares in arrivent biopharma, inc. (nasdaq:avbp) Defense World Sat, 12 Apr 2025 07:00:00 GMT
• corebridge financial inc. has $373,000 stake in arrivent biopharma, inc. (nasdaq:avbp) Defense World Thu, 10 Apr 2025 07:00:00 GMT
• charles schwab investment management inc. has $5.50 million stake in arrivent biopharma, inc. (nasdaq:avbp) Defense World Wed, 26 Mar 2025 07:00:00 GMT
• b. riley initiates arrivent biopharma at buy with $37 price target -march 20, 2025 at 07:13 am edt Marketscreener.com Thu, 20 Mar 2025 11:20:44 GMT
• this microsoft analyst begins coverage on a bullish note; here are top 5 initiations for thursday Benzinga Thu, 20 Mar 2025 07:00:00 GMT
• arrivent biopharma (avbp): among the best short squeeze stocks to buy according to analysts Yahoo Finance Wed, 19 Mar 2025 07:00:00 GMT
• new york state common retirement fund boosts holdings in arrivent biopharma, inc. (nasdaq:avbp) Defense World Thu, 06 Mar 2025 08:00:00 GMT
• is tesla stock a buy, sell, or hold after rare auto supplier acquisition? The Globe and Mail Tue, 04 Mar 2025 08:00:00 GMT
• ArriVent BioPharma Reports Full Year 2024 Financial Results The Manila Times Mon, 03 Mar 2025 08:00:00 GMT
• arrivent biopharma, inc. (nasdaq:avbp) short interest update MarketBeat Mon, 03 Feb 2025 02:08:51 GMT
• arrivent biopharma secures global rights to mrg007 in strategic deal with lepu biopharma MSN Mon, 27 Jan 2025 08:36:23 GMT
• why logility supply chain solutions shares are trading higher by over 23%; here are 20 stocks moving premarket Benzinga Mon, 27 Jan 2025 08:00:00 GMT
• hc wainwright issues optimistic forecast for avbp earnings MarketBeat Fri, 24 Jan 2025 12:59:57 GMT
• arrivent biopharma secures global rights to mrg007 in strategic deal with lepu biopharma MSN Fri, 24 Jan 2025 12:20:58 GMT
• more china adcs: arrivent gets gi cancer drug in $1.2b lepu deal BioWorld Online Thu, 23 Jan 2025 14:00:00 GMT
• arrivent biopharma price target raised to $39 from $36 at h.c. wainwright Yahoo Finance Thu, 23 Jan 2025 08:00:00 GMT
• arrivent bets big on experimental cancer drug with potential $1b licensing deal The Business Journals Wed, 22 Jan 2025 16:06:00 GMT
• arrivent biopharma (nasdaq:avbp) price target raised to $39.00 MarketBeat Wed, 22 Jan 2025 14:11:29 GMT
• arrivent biopharma (nasdaq:avbp) stock price expected to rise, hc wainwright analyst says MarketBeat Wed, 22 Jan 2025 08:00:00 GMT
• lepu biopharma co., ltd. enters into an exclusive licensing agreement with arrivent biopharma, inc Marketscreener.com Wed, 22 Jan 2025 04:19:00 GMT
• arrivent biopharma enters exclusive license with lepu biopharma WICZ Wed, 22 Jan 2025 00:10:00 GMT
• lepu biopharma grants exclusive license for novel adc mrg007 to arrivent TipRanks Wed, 22 Jan 2025 00:09:22 GMT
• arrivent biopharma secures global rights to promising cancer drug mrg007 in $1.2b deal StockTitan Tue, 21 Jan 2025 08:00:00 GMT
• arrivent biopharma, inc. (nasdaq:avbp) short interest up 13.1% in december MarketBeat Sun, 19 Jan 2025 08:00:00 GMT
• arrivent biopharma (nasdaq:avbp) shares gap down - what's next? MarketBeat Fri, 17 Jan 2025 16:24:33 GMT
• 12 health care stocks moving in thursday's pre-market session Benzinga Thu, 16 Jan 2025 08:00:00 GMT
• jane street group llc cuts stake in nexpoint diversified real estate trust (nyse:nxdt) Defense World Wed, 15 Jan 2025 10:15:01 GMT
• barclays plc boosts position in arrivent biopharma, inc. (nasdaq:avbp) MarketBeat Wed, 15 Jan 2025 08:00:00 GMT
• biopharma ipos rebound slightly, as class of 2024 lags with a 29% average decline BioWorld Online Thu, 09 Jan 2025 08:00:00 GMT
• these were the winners and losers in a boring year for startup ipos Crunchbase News Mon, 09 Dec 2024 08:00:00 GMT
• janux therapeutics announces closing of underwritten public offering of common stock and pre-funded warrants including full exerci... BioSpace Mon, 09 Dec 2024 08:00:00 GMT
• aclaris therapeutics announces new employee stock grants under 2024 inducement plan MyChesCo Thu, 05 Dec 2024 08:00:00 GMT
• medicus pharma completes ipo, becomes second local life sciences company to go public in 2024 The Business Journals Fri, 15 Nov 2024 08:00:00 GMT
• arrivent biopharma reports third quarter 2024 financial results The Manila Times Thu, 14 Nov 2024 08:00:00 GMT
• arrivent reports $282.9m cash position, firmonertinib shows promise in nsclc trial StockTitan Thu, 14 Nov 2024 08:00:00 GMT
• arrivent biopharma, inc. reports earnings results for the third quarter and nine months ended september 30, 2024 Marketscreener.com Thu, 14 Nov 2024 08:00:00 GMT
• medicus pharma readies for ipo as it targets $20b industry The Business Journals Fri, 08 Nov 2024 08:00:00 GMT
• discover the 3 best-performing biotech ipo stocks of 2024 MarketBeat Wed, 06 Nov 2024 08:00:00 GMT
ArriVent BioPharma Inc. Common Stock(NASDAQ:AVBP) 
None
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends